• By ICR Secretariat
  • Posted Thursday, October 20, 2022

Atara on verge of landmark approval for first allogeneic T-cell therapy

https://www.fiercepharma.com/pharma/atara-verge-landmark-approval-first-allogenic-t-cell-therapy

With a thumbs up from Europe’s Committee for Medicinal Products for Human Use (CHMP), Atara Biotherapeutics’ Ebvallo is poised to become the first allogeneic T-cell therapy approved in the world.